| 期 |
标题 |
文件 |
| 编号 4 (2013) |
Matrix metalloproteinases in priogression of hereditary kidney disease |
|
|
Bashirova Z.
|
| 编号 4 (2013) |
Neutrophil gelatinase-associated lipocalin in diagnosis of kidney diseases |
|
|
Eraliev A., Demeubaeva D., Naushabaeva A., Kabulbaev K., Chingaeva G., Abeouva B., Dosym S., Kanatbaeva A.
|
| 编号 6 (2011) |
Role of omega-3 unsaturated fatty acids in treatment of progressive kidney diseases |
|
|
Kulina E.
|
| 编号 1 (2012) |
Role of R990G polymorphism of calcium-sensing receptor gene in regulation of parathyroid hormone level in children with chronic kidney disease stage III-V |
|
|
Molchanova M., Tikhomirov E., Bykova L., Molchanova E., Rumyantsev A., Valov A., Ektov D., Ektov V., Yurasova Y., Petrosyan E., Molchanova M., Tikhomirov E., Bykova L., Molchanova E., Rumiantsev A., Valov A., Ektov D., Ektov V., Yurasova Y., Petrosian E.
|
| 卷 12, 编号 2 (2020) |
The role of patient’s adherence in the treatment of hyperphosphatemia in chronic kidney disease |
|
|
Esayan A., Rind A.
|
| 编号 5 (2013) |
Role of plant medicines in treatment of renal diseases |
|
|
Bratchikov O.
|
| 编号 2 (2015) |
The role of extracorporeal membrane oxygenation in modern medicine and its prospects in organ donation |
|
|
Stepanov V., Korshunov K., Jankovoj A.
|
| 卷 13, 编号 2 (2021) |
The role of oxidative stress in the development of protein-energy wasting and sarcopenia in patients with stage 5D chronic kidney disease |
|
|
Gasanov M., Negoda V., Batyushin M.
|
| 编号 1 (2019) |
Clinical practice guidelines for peritoneal dialysis in patients with chronic kidney disease stage 5 (CKD 5) |
|
|
Shutov E., Kotenko O.
|
| 卷 12, 编号 1 (2020) |
Kaposi’s Sarcoma in a patient with focal segmental glomerulosclerosis |
|
|
Grigoryeva E., Bazarkina M., Bikeeva E.
|
| 编号 1 (2018) |
The relationship between blood pressure parameters and chronic heart failure in patients on hemodialysis |
|
|
Borodulina E., Shutov A.
|
| 编号 5-6 (2012) |
Perspectives of sevelamer in hyperphosphatemia treatment in patients with chronic kidney disease stage III-V |
|
|
Milovanova L., Milovanov Y., Dobrosmislov I., Moiseev S.
|
| 编号 2 (2012) |
Selective activation VDR - pioneering approach to prevention and treatment of secondary hyperpara-thyreoidism, cardio- and renoprotecton |
|
|
Shilo V., Shilo V.
|
| 卷 12, 编号 2 (2020) |
Selective screening for Fabry disease: review of literature data and experience in the Russian Federation |
|
|
Ilyushkina A., Baydakova G., Bychkov I., Buruleva N., Zakharova E.
|
| 编号 2 (2014) |
Cardiovascular risk and chronic kidney disease: cardioand nephroprotection strategies |
|
|
- -.
|
| 编号 5-6 (2012) |
“Simbiotic” approach to compensation of chronic kidney disease in human |
|
|
Yumatov E., Sudakov K.
|
| 编号 1 (2010) |
RENAL SYMPATHETIC DENERVATION AN INNOVATIVE METHOD OF TREATMENT OF RESISTANT ARTERIAL HYPERTENSION |
|
|
- -.
|
| 编号 4 (2009) |
TUBULO-INTERSTITIAL NEPHRITIS WITH UVEITIS SYNDROME |
|
|
- -.
|
| 编号 2 (2011) |
FANCONI SYNDROME |
|
|
- -.
|
| 编号 2 (2019) |
Nutcracker syndrome in nephrology practice |
|
|
Movchan E., Manakova Y., Galkina E., Telegina T.
|
| 编号 2 (2016) |
Simultaneous cancer in renal transplant recipient |
|
|
Yankovoi A., Prokopenko E., Gurevich L., Zul’karnaev A., Maister T.
|
| 卷 15, 编号 4 (2023) |
Systematic review and meta-analysis of the effect of calcineurin inhibitors on long-term prognosis in kidney transplant recipients |
|
|
Novikova M., Minushkina L., Kotenko O., Zateyshchikov D., Boeva O., Allazova S., Shilov E.
|
| 编号 2 (2019) |
Glomerular filtration rate, traditional cardiovascular risk factors, and carotid intima-media thickness in patients with rheumatoid arthritis |
|
|
Tyapkina M., Karpova O., Ponomareva E., Rebrov A.
|
| 卷 12, 编号 4 (2020) |
Glomerular filtration rate in patients with spondiloarthritis against the ackground of long-term therapy with NSAIDS -results of prospective observational study |
|
|
Rebrov A., Aparkina A.
|
| 卷 16, 编号 1 (2024) |
Screening for sarcopenia in patients with chronic heart failure and chronic kidney disease |
|
|
Sokolova A., Dragunov D., Arutyunov G.
|
| 卷 12, 编号 3 (2020) |
Difficulties in differential diagnosis of different variants of TMA: from urgent to"silent''forms with life-threatening consequences |
|
|
Kirsanova T.
|
| 编号 1 (2011) |
SYSTEMIC AMYLOIDOSIS IN PATIENT WITH GOUT |
|
|
Voloshinova E., Lobanova O., Nikitina N.
|
| 卷 15, 编号 1 (2023) |
Mortality among kidney transplant recipients with SARS-CoV-2: a systematic review and meta-analysis of cohorts and clinical registries |
|
|
Novikova M., Minushkina L., Kotenko O., Zateyshchikov D., Boeva O., Allazova S., Shilov E., Koteshkova O., Antsiferov M.
|
| 卷 15, 编号 1 (2023) |
Mortality in kidney transplant recipients: a systematic review and meta-analysis of cohorts and clinical registries |
|
|
Novikova M., Minushkina L., Kotenko O., Zateyshchikov D., Boeva O., Allazova S., Shilov E.
|
| 编号 1 (2014) |
Development of diagnosis of specific and non-specific lesions of upper urinary tract |
|
|
Zuban’ O., Ckorniakov C., Novikov B., Borodin E., Arkanov L.
|
| 编号 1 (2019) |
Combined positron-emission tomographyand computed tomography scanning of the kidneys and urinary tract |
|
|
Berdichevsky V., Berdichevsky B., Zhmurov V., Barashin D., Rasulov F., Romanova A., Pavlova I., Zagorchik E.
|
| 编号 2 (2016) |
Modern strategy for erythropoiesis-stimulating therapy in chronic kidney disease |
|
|
Vetchinnikova O.
|
| 编号 1 (2011) |
The current state of problem of kidney tumors and analysisof rational approaches to medical interventions |
|
|
Galeev R., Khamitov D.
|
| 编号 5 (2014) |
Modern aspects of renal transplantation as a variant of renal replacement therapy |
|
|
Krstich M., Zul'karnaev A.
|
| 编号 1 (2017) |
Contemporary opportunities for using phosphate binders in dialysis patients |
|
|
Gorelova E., Chernysheva N., Kotenko O., Shutov E.
|
| 编号 4 (2012) |
Sovremennye vozmozhnosti rastvoreniya uratnykh kamney mochetochnika |
|
|
Alyaev Y., Dzeranov N., Rapoport L., Tsarichenko D., Frolova E.
|
| 编号 4 (2014) |
Modern methods of treatment of ischemic/ reperfusion damage of renal allograft |
|
|
Vatazin A., Nesterenko I., Zul’karnaev A., Shakhov N.
|
| 卷 12, 编号 3 (2020) |
Modern approaches to the diagnosis and treatment of atypical hemolytic uremic syndrome: analysis of clinical cases |
|
|
Krivushkin S.
|
| 编号 1 (2014) |
Therapy of ANCA-associated systemic vasculitides: current approaches |
|
|
Novikov P., Moisseev S., Bulanov N., Makarov E.
|
| 编号 2 (2013) |
Congenital anomalies of kidney and urinary tract syndrome in children: modern statement |
|
|
Ignatova M., Morozov S., Kryganova T., Shentseva D., Nazarova N., Konkova N., Dlin V.
|
| 编号 1 (2016) |
Modern concept of the renal transport mechanisms of uric acid |
|
|
Zverev Y., Bryukhanov V.
|
| 编号 2 (2010) |
Update on renal affection in obesity |
|
|
Saginova E., Gallyamov M., Severova M., Saginova E., Gallyamov M., Severova M.
|
| 卷 16, 编号 1 (2024) |
Modern concepts of the role of asymptomatic hyperuricemia in the formation of chronic kidney disease and cardiovascular risk |
|
|
Dudnikova A., Mekhrabov R., Alieva A., Gish Z., Leontyev A., Rasskazova D.
|
| 编号 1 (2011) |
CILIOPATHIES: CURRENT CONCEPTS |
|
|
- -.
|
| 编号 2 (2013) |
Modern strategies of correction of metabolism of chronic kidney disease |
|
|
- -.
|
| 卷 14, 编号 4 (2022) |
Modern strategies for the treatment of patients with autosomal dominant polycystic kidney disease |
|
|
Trushkin R., Medvedev P., Isaev T., Klementieva T., Morozov N., Ivanov K.
|
| 卷 16, 编号 3 (2024) |
Current trends in requirements for a donor organ in kidney transplantation |
|
|
Trushkin R., Medvedev P., Sokolov S., Shcheglov N., Sokolov A.
|
| 编号 5-6 (2015) |
Modern view on mechanisms of uric acid nephrolithiasis |
|
|
Zverev J., Brjuhanov V.
|
| 编号 1 (2018) |
Modern view on the sodium exchange |
|
|
Dragunov D., Arutyunov G., Sokolova A.
|
| 编号 5 (2013) |
Modern approaches to treatment of septic complications and urosepsis in patients with urological diseases on renal replacement therapy |
|
|
Krstich M., Zulkarnaev A.
|
| 编号 3 (2018) |
Blood plasma cystatin c level and its relationship with the augmentation index and central arterial pressure in therapeutic patients |
|
|
Murkamilov I., Aitbaev K., Fomin V., Murkamilova Z., Sabirov I.
|
| 卷 16, 编号 3 (2024) |
Relationship of the concepts “medical service” and “medical care” |
|
|
Lipatnikova V.
|
| 编号 1 (2016) |
Averting the legacy of kidney disease -focus on childhood |
|
|
Ingelfinger J., Kalantar-Zadeh K., Schaefer F.
|
| 编号 2 (2017) |
The state of the vegetative homeostasis and the quality of life of children with neurogenic urination disorders against the background of connective tissue dysplasia |
|
|
Latyshev D., Lobanov Y., Mikheeva N., Tekutyeva N., Kvasova A.
|
| 编号 1 (2012) |
Left ventricular diastolic function in nephrogenic arterial hypertension in patients with preserved renal function |
|
|
Borovkova N., Borovkov N., Biryukova L., Obukhova E., Khor'kina Y., Arshinova A., Borovkova N., Borovkov N., Biriukova L., Obukhova E., Khorkina Y., Arshinova A.
|
| 卷 13, 编号 1 (2021) |
State of renal replacement therapy for chronic kidney disease in Moscow in 2015-2020 |
|
|
Kotenko O., Vasina N., Marchenkova L., Lysenko M.
|
| 编号 2 (2012) |
Lipid metabolism in chronic kidney disease |
|
|
Rudenko T., Kutyrina I., Shvetsov M., Rudenko T., Kutyrina I., Shvetsov M.
|
| 编号 2 (2010) |
State of microcirculation and microalbuminuria in patients with arterial hypertension |
|
|
Sirotin B., Zhmerenetskiy K., Zhmerenetskaya E., Sirotin B., Zhmerenetskii K., Zhmerenetskaya E.
|
| 卷 14, 编号 1 (2022) |
The state of the nephrological service in the Russian Federation: renal replacement therapy in the period from 2017 to 2021 |
|
|
Shilov E., Shilova M., Rumyantseva E., Yesayan A., Kotenko O.
|
| 卷 12, 编号 1 (2020) |
State of the nephrological service: renal replacement therapy in the Russian Federation from 2015 to 2019 |
|
|
Shilov E., Kotenko O., Shilova M., Milchakov K., Gabaev M., Khalfin R.
|
| 编号 2 (2013) |
Kidney in patients survived in hantaan and puumala virus-induced nephropathy |
|
|
Sirotin B.
|
| 卷 12, 编号 2 (2020) |
Kidney condition in patients with spondyloarthritis receiving genetically engineered biologic drugs |
|
|
Dorogoykina K., Sedov D., Gamayunova K., Rebrov A.
|
| 卷 14, 编号 2 (2022) |
The hemostasis system in patients with acute renal injury |
|
|
Ryazantsev V., Vlasov A., Stepanov N.
|
| 编号 3 (2013) |
Urodynamic parameters in children with chronic pyelonephritis |
|
|
Nesterenko O., Goremykin V.
|
| 卷 12, 编号 3 (2020) |
Social support for ckd patients on dialysis in an inpatient social institution |
|
|
Yakunin A., Sheykhov M., Kotenko O., Kondrashova L., Vasina N.
|
| 卷 12, 编号 2 (2020) |
The Combination of Goodpasture syndrome and granulomatosis with polyangiitis |
|
|
Vetsheva M., Podkorytova O., Artyukhina L., Loss K., Lysenko M.
|
| 卷 16, 编号 2 (2024) |
Combined congenital anomaly of the bladder and urethra in a child. Possibilities of surgical treatment |
|
|
Morozov S., Kursova T., Podgorny A., Polishchuk L., Grigoryan L., Piruzieva O., Petukhova E.
|
| 编号 1 (2015) |
Coupled plasma filtration adsorption in the treatment of s sepsis in patients after kidney transplantation |
|
|
Vatazin A., Zul'karnaev A., Krstich M., Kantarija R.
|
| 编号 3 (2009) |
Associated kidney and liver diseases in children |
|
|
Tsigin A.
|
| 编号 3 (2011) |
Unresolved questions of diabetic nephropathy (part I) |
|
|
Volkova N., Antonenko M.
|
| 编号 1 (2009) |
Controversies in ACE inhibitors use |
|
|
Martynov A., Mukhin N., Gilyarevskiy S., Fomin V., Mukhin N., Martynov A., Gyliarevsky S., Fomin V.
|
| 卷 15, 编号 2 (2023) |
Method for surgical treatment of bladder cancer in patients with end-stage renal disease on renal replacement therapy with program hemodialysis simultaneously with treatment and prevention of purulent pyelonephritis. Review of clinical cases |
|
|
Trushkin R., Martov A., Sokolov S., Isaev T., Shcheglov N., Teikhrib P.
|
| 卷 15, 编号 1 (2023) |
Comparison of diagnostic significance of calculation of glomerular filtration rate based on creatinine and cystatin c in patients with chronic obstructive pulmonary disease |
|
|
Bolotova E., Dudnikova A.
|
| 卷 12, 编号 1 (2020) |
Comparison of risk factors for developing post-transplant diabetis mellitus in patients with kidney allograft |
|
|
Allazova S., Novikova M., Kotenko O., Shilov E.
|
| 编号 2 (2016) |
Comparative informativeness of proteinuria tests in patients with chronic obstructive pulmonary disease |
|
|
Bolotova E., Dudnikova A.
|
| 编号 2 (2014) |
Comparative clinical and age-related features and criteria for evaluating the results of treatment of urinary tract tuberculosis |
|
|
Skornyakov S., Zuban O., Novikov B., Borodin E., Arkanov L., Medvinsky I., Fadina O.
|
| 编号 2 (2015) |
Comparative evaluation of the efficacy of medical treatment programs of primary multi-symptom enuresis in children |
|
|
Zastelo E., Haleckaja O., Tush E.
|
| 卷 12, 编号 3 (2020) |
Comparative evaluation of the structure of cardiovascular diseases of the rural and urban population of the republic of uzbekistan, suffering from stage 5 CKD on programmed hemodialysis |
|
|
Sharapov O., Daminov B., Yarygina S., Dyagilev V.
|
| 卷 16, 编号 1 (2024) |
Comparative pharmacoeconomic analysis of the use of epoetin alfa and roxadustat in combination with iron supplements in adult patients with anemia against the background of chronic kidney disease in the healthcare system of the Russian Federation |
|
|
Krysanov I., Makarova E., Ermakova V., Kurkin D.
|
| 编号 3 (2011) |
steroid resistant nephrotic syndrome in childhood: Single-centre experience |
|
|
Fomina S., Bagdasarova I., Pavlenko T.
|
| 卷 13, 编号 4 (2021) |
The costs of chronic kidney disease in Russian Federation |
|
|
Kotenko O., Omelyanovskiy V., Ignatyeva V., Yagnenkova E., Rumyantseva E.
|
| 编号 1 (2014) |
Stratifikatsiya riska razvitiya khronicheskoy bolezni pochek s pomoshch'yu anketirovaniya |
|
|
Nagaitseva S., Shvetsov M., Gerasimov A., D Shalyagin Y., Ivanova E., Shilov E.
|
| 卷 12, 编号 2 (2020) |
Stress-induced cardiomyopathy in a patient with a fulminant course of COVID-19 early after a kidney allotransplantation |
|
|
Zeltyn-Abramov E., Belavina N., Frolova N., Artyukhina L., Podkorytova O., Varyasin V., Parshin V., Maksimov I., Evsyukov O., Shishchenko E.
|
| 编号 2 (2011) |
Structure of morphological changes in kidneys and role of kidney biopsy in correction of treatment strategy of nephropathies in Moscow region residents |
|
|
Lyubchenko P., Urenkov S., Stolyarevich E., Budnikova N., Stotskaya T., Atamanchuk A., Vinogradov A.
|
| 编号 1 (2011) |
Сauses of death in patients receiving program heamodalysis |
|
|
Rtishcheva O., Kalev O., Akhmatov V.
|
| 编号 5-6 (2012) |
Structural and functional interrelations of changes of cardiorenal system in pregnant women with chronic arterial hypertension |
|
|
Chicherina E., Padyganova A.
|
| 编号 1 (2012) |
Role of sulodexide in treatment of diabetic nephropathy in patients with type 1 diabetes mellitus |
|
|
Aleksandrovich G., Andreeva E., Markova A., Morozova N., Saneeva G., Unanova I., Alexandrovich G., Andreeva E., Markov A., Morozova N., Saneeva G., Unanova I.
|
| 编号 3 (2012) |
SULODEKSID (VESSEL DUE F) - NOVYE PERSPEKTIVY V NEFROPROTEKTIVNOY TERAPII |
|
|
Batyushin M., Galushkin A., Poganeva V., Asrumyan E., Litvinov A., Sadovnichaya N., Tsvetkov D., Rudenko L.
|
| 编号 2 (2013) |
Sulodexide and chronic kidney disease: clinical and experimental studies |
|
|
Svistunov A., Fomin V.
|
| 编号 2 (2013) |
Serum levels of morphogenetic proteins (fibroblast growth factor-23 and Klotho): clinical significance |
|
|
Milovanova L., Milovanov Y., Kozlovskaya L., Moukhin N.
|
| 编号 1 (2015) |
Role of serum alpha-Klotho and FGF-23 in cardiovascular calcification |
|
|
Rudenko L., Batjushin M., Kastanajan A., Vorob'ev B., Sarvilina I.
|
| 编号 1 (2015) |
Strategy of drug therapy selection in patients with hypertension and renal tubulointersticial injury |
|
|
Sokolova A., Dragunov D., Arutjunov G.
|
| 编号 2 (2018) |
Telemedicine - relevance and problems. IT-technologies in peritoneal dialysis |
|
|
Shutov E., Kotenko O.
|
| 卷 15, 编号 2 (2023) |
Teleguidance of patients on ambulatory peritoneal dialysis using the "Telenefrocenter" platform for remote monitoring and rehabilitation |
|
|
Berdinsky V., Ivanova E., Kotenko O., Kargalskaya I., Vinogradov V., Frolova N.
|
| 编号 1 (2014) |
Therapeutic tactics in tertiary hyperparathyroidism after renal transplantation (Review and clinical observations) |
|
|
Vetchinnikova O., Kantariya R.
|
| 卷 16, 编号 2 (2024) |
Treatment of dyslipidemia using inclisiran in a case series of patients after kidney and liver transplantation |
|
|
Kordonova O., Gubarev K., Frolova N., Svetlakova D., Voskanyan S., Artyukhina L.
|
| 卷 14, 编号 4 (2022) |
Therapy for immunoglobulin А-nephropathy: what along with immunosuppression? |
|
|
Bobkova I., Kamyshova E.
|
| 编号 2 (2018) |
Autologous blood stem cell transplantation in patients with myelome nephropathy: description of 2 clinical cases |
|
|
Karimova E., Baryakh E., Zhelnova E., Misyurina E., Yaiskov K., Karpova O., Kazaryan S., Bulanov A.
|
| 编号 3 (2018) |
Transplantation of kidney with double ureter |
|
|
Yankovoy A., Stepanov V., Sinyutin A.
|
| 编号 2 (2018) |
Kidney transplantation in a patient after traumatic ligation of the inferior vena cava |
|
|
Yankovoy A., Sinyutin A., Stepanov V.
|
| 701 - 800 的 925 信息 |
<< < 1 2 3 4 5 6 7 8 9 10 > >> |
